Growth Metrics

Western Uranium & Vanadium (WSTRF) EBIT (2016 - 2025)

Western Uranium & Vanadium (WSTRF) has disclosed EBIT for 8 consecutive years, with -$1.2 million as the latest value for Q3 2025.

  • On a quarterly basis, EBIT rose 49.09% to -$1.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$8.6 million, a 7.04% increase, with the full-year FY2024 number at -$10.3 million, down 102.81% from a year prior.
  • EBIT was -$1.2 million for Q3 2025 at Western Uranium & Vanadium, up from -$2.0 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $2.3 million in Q2 2022 to a low of -$2.8 million in Q4 2024.
  • A 5-year average of -$1.3 million and a median of -$1.2 million in 2022 define the central range for EBIT.
  • Biggest YoY gain for EBIT was 679.87% in 2022; the steepest drop was 304.96% in 2022.
  • Western Uranium & Vanadium's EBIT stood at -$713520.0 in 2021, then tumbled by 87.22% to -$1.3 million in 2022, then fell by 29.11% to -$1.7 million in 2023, then plummeted by 62.0% to -$2.8 million in 2024, then skyrocketed by 58.06% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for WSTRF's EBIT are -$1.2 million (Q3 2025), -$2.0 million (Q2 2025), and -$2.7 million (Q1 2025).